Main Menu

Translational Immunotherapy Team

Professor Alan Melcher's team is looking at ways to activate the immune system to attack cancer using therapeutic viruses. These agents are already approved for clinical use and offer major potential benefits to further improve the promising field of immunotherapy.

Team leader

Professor Alan Melcher

Professor Alan Melcher

Professor of Translational Immunotherapy

Professor Melcher is a clinician scientist studying how to activate the immune system to recognise and attack cancer. In particular, he works on oncolytic, anti-cancer viruses, which work mainly as a type of immunotherapy, and is a specialist in melanoma.

ORCID 0000-0002-2042-3380

Team members

Dr Shane Foo

Higher Scientific Officer